Thursday, January 24, 2013

Final FDA rule on device, drug and biologic combos is available

Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/eijaCduTtWCfuPgjCidncVCicNYltU


January 24, 2013
BIO has teamed up with FedEx to offer member companies discounts of up to 35% off select FedEx Express, FedEx Ground and FedEx Home Delivery services through the BIO Business Solutions cost-savings program. Learn more.

The news summaries appearing in BIO SmartBrief are based on original information from news organizations and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The information is not compiled or summarized by BIO. Questions and comments should be directed to SmartBrief at bio@smartbrief.com.

  Today's Top Story 
  Health Care & Policy 
  • Celgene seeks FDA approval of Abraxane for pancreatic cancer
    Celgene plans to submit Abraxane, or paclitaxel, within the next five months for FDA approval as a treatment for pancreatic cancer after obtaining promising results from a Phase III study. Patients with advanced pancreatic cancer who took Abraxane, in combination with gemcitabine, had median overall survival of 8.5 months versus 6.7 months for those given gemcitabine alone. Abraxane is already cleared for lung and breast cancer. Reuters (1/22) LinkedInFacebookTwitterEmail this Story
  • Scientists use Shakespeare to explore DNA's storage capacity
    Scientists at the European Bioinformatics Institute used DNA to write out all 154 of William Shakespeare's sonnets and encode audio portions of Martin Luther King Jr.'s "I Have a Dream" speech to show the vast storage capabilities of DNA strands. Scientists say one gram of DNA is capable of holding more than a million CDs and could be a new way to digitally store massive amounts of information for thousands of years. The Guardian (London) (1/23) LinkedInFacebookTwitterEmail this Story
  Company & Financial News 
  • J&J considers potential sale or spinoff of diagnostics biz
    Johnson & Johnson said it is exploring a possible sale or spinoff of its Ortho Clinical Diagnostics unit, which develops laboratory and blood transfusion testing tools. The company made the disclosure after reporting better-than-expected quarterly profits, driven by strong sales of its artificial hips and knee implants. Reuters (1/22) LinkedInFacebookTwitterEmail this Story
  Industry Deals 
  Food & Agriculture 
  • Cereal makers explain biotech crops' safety and benefits
    Kellogg and General Mills stood behind the use of biotech ingredients in their breakfast cereals in response to calls to either label or remove them in their products. Biotech crops are safe and provide more food with fewer pesticides, Kellogg spokesman Kris Charles said. General Mills, meanwhile, reiterated its objections to state-by-state labeling policies. FoodNavigator (1/23) LinkedInFacebookTwitterEmail this Story
  Industrial & Environmental 
  • Congress is asked to reinstate funding to farm bill's energy programs
    The Agriculture Energy Coalition is asking Congress to pass a new five-year farm bill with fully funded energy programs. "Farm energy programs have paid a tremendous return for rural Americans, in terms of new jobs, investments in new energy efficiency and bioenergy technology, and new biobased products," said Lloyd Ritter, co-director of the coalition. The "fiscal cliff" package approved by Congress earlier this month extended the 2008 farm bill but stripped its energy programs of funding. DomesticFuel.com (1/22) LinkedInFacebookTwitterEmail this Story
The Buzz(CORPORATE ANNOUNCEMENTS)

Interested in learning more about advertising in BIO SmartBrief? Contact Meryl Harold at (202) 407-7828 or mharold@smartbrief.com. 

  News from BIO 
  • Are you taking full advantage of your membership?
    BIO's cost-savings program, BIO Business Solutions, is helping 2,700 companies nationwide save on the cost of essential products and services. Members of BIO and 43 state and regional biotech associations are eligible to receive preferential pricing and other benefits at no additional cost beyond their membership dues. VWR International, FedEx, Office Depot and Business Wire are just a few of the industry leading providers that offer special pricing through this members-only program. Learn more or enroll here. LinkedInFacebookTwitterEmail this Story
Learn more about BIO ->Conferences  |  Join BIO  |  Media  |  Issues  |  Industry

  SmartQuote 
All news is an exaggeration of life."
--Daniel Schorr,
American journalist


LinkedInFacebookTwitterEmail this Story

 
 
This SmartBrief was created for jmabs1@gmail.com
 
Subscriber Tools
     
Update account information | Change e-mail address | Unsubscribe | Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Account Director:  Meryl Harold (202) 407-7828
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent BIO SmartBrief Issues:   Lead Editor:  Tom Parks
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information

No comments: